A Fortune 500 company, in conjunction with IBM Watson Health, conducted an economic evaluation to test whether our flagship digital therapeutic for insomnia, Sleepio, would lower health care costs for their employees.
Individuals who used Sleepio had 28% lower annualized total healthcare costs compared to those who did not use Sleepio — demonstrating $1,677 lower health care costs per employee that used Sleepio.
A peek inside:
Here’s our latest
The vicious cycle of insomnia and anxiety
When insomnia and anxiety occur together, their effects can compound. A remarkable 24% to 36% of people with anxiety disorders…
The impact of good mental health in the financial services industry
Our report presents all the evidence you’ll need to make the business case for investing in employee mental health.
The impact of good mental health in manufacturing
Our report gives you all the evidence you need to make the case for investing in employee mental health through…